AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
3min chapter
Which patients might benefit the most from isatuximab-based combinations in the relapsed setting?
Multiple Myeloma Hub
Exploring the Efficacy of Isatuximab-Based Combinations in Relapsed Multiple Myeloma
Exploring the efficacy and benefits of Isatuximab in combination with carfilzomib and dexamethasone for treating multiple myeloma patients refractory to lenalidomide-based therapy, emphasizing the role of immunomodulatory agents in improving outcomes.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode